TransCode Therapeutics analyst ratings
TransCode Therapeutics analyst ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
06/07/2022 | 468.18% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
---|---|---|---|---|---|
06/07/2022 | 468.18% | HC Wainwright & Co. | → 10 美元 | 开启覆盖范围 | → 购买 |
TransCode Therapeutics Questions & Answers
TransCode 治疗问题与解答
The latest price target for TransCode Therapeutics (NASDAQ: RNAZ) was reported by HC Wainwright & Co. on June 7, 2022. The analyst firm set a price target for $10.00 expecting RNAZ to rise to within 12 months (a possible 468.18% upside). 1 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2022年6月7日公布了TransCode Therapeutics(纳斯达克股票代码:RNAZ)的最新目标股价。这家分析公司将目标价设定为10.00美元,预计RNAZ将在12个月内升至468.18%(可能上涨468.18%)。1家分析公司去年公布了评级。
The latest analyst rating for TransCode Therapeutics (NASDAQ: RNAZ) was provided by HC Wainwright & Co., and TransCode Therapeutics initiated their buy rating.
TransCode Therapeutics(纳斯达克股票代码:RNAZ)的最新分析师评级由HC Wainwright & Co. 提供,TransCode Therapeutics启动了买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TransCode Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TransCode Therapeutics was filed on June 7, 2022 so you should expect the next rating to be made available sometime around June 7, 2023.
分析师在进行了广泛的研究后得出了股票评级,包括浏览公开财务报表,与TransCode Therapeutics的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月这样做一次,因此每家公司每年应该获得4次评级。TransCode Therapeutics的最新评级是在2022年6月7日提交的,因此你应该预计下一个评级将在2023年6月7日左右公布。
While ratings are subjective and will change, the latest TransCode Therapeutics (RNAZ) rating was a initiated with a price target of $0.00 to $10.00. The current price TransCode Therapeutics (RNAZ) is trading at is $1.76, which is within the analyst's predicted range.
虽然评级是主观的,而且会发生变化,但最新的TransCode Therapeutics(RNAZ)评级是最初的,目标价为0.00美元至10.00美元。TransCode Therapeutics(RNAZ)目前的交易价格为1.76美元,在分析师的预测区间内。